8-Ethinylxanthine derivatives as selective A2A receptor antagonists

Details for Australian Patent Application No. 2007338413 (hide)

International Classifications

Event Publications

23 April 2009 PCT application entered the National Phase

PCT publication WO2008/077557 Priority application(s): WO2008/077557

23 July 2009 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read from Hockenmeyer, Joerg to Hockemeyer, Joerg

10 June 2010 Alteration of Name

The name of the applicant has been altered to UCB Pharma GmbH 2008

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.